CSL regulates AKT to mediate androgen independence in prostate cancer progression

Androgen deprivation–induced NCoA2 promotes metastatic and castration-resistant prostate cancer

(2014) Jun Qin et al.   JOURNAL OF CLINICAL INVESTIGATION

Role of Androgen Receptor in Progression of LNCaP Prostate Cancer Cells from G1 to S Phase

(2013) Shalini Murthy et al.   PLoS One

Suppression of Acquired Docetaxel Resistance in Prostate Cancer through Depletion of Notch- and Hedgehog-Dependent Tumor-Initiating Cells

(2012) Josep Domingo-Domenech et al.   CANCER CELL

Antagonists of growth hormone-releasing hormone inhibit growth of androgen-independent prostate cancer through inactivation of ERK and Akt kinases

(2012) F. G. Rick et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

The double-edged sword of Notch signaling in cancer

(2012) Andrew P. South et al.   SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY

Akt signalling in health and disease

(2011) Ingeborg Hers et al.   CELLULAR SIGNALLING

Androgen receptor levels are upregulated by Akt in prostate cancer

(2011) S. Ha et al.   ENDOCRINE-RELATED CANCER

Down regulation of CSL activity inhibits cell proliferation in prostate and breast cancer cells

(2011) Thomas Yong et al.   JOURNAL OF CELLULAR BIOCHEMISTRY

Notch Activation by Phenethyl Isothiocyanate Attenuates Its Inhibitory Effect on Prostate Cancer Cell Migration

(2011) Su-Hyeong Kim et al.   PLoS One

Novel targets for prostate cancer chemoprevention

(2010) Fazlul H Sarkar et al.   ENDOCRINE-RELATED CANCER

Molecular genetics of prostate cancer: new prospects for old challenges

(2010) M. M. Shen et al.   GENES & DEVELOPMENT

Down-regulation of Notch-1 is associated with Akt and FoxM1 in inducing cell growth inhibition and apoptosis in prostate cancer cells

(2010) Zhiwei Wang et al.   JOURNAL OF CELLULAR BIOCHEMISTRY

The Canonical Notch Signaling Pathway: Unfolding the Activation Mechanism

(2009) Raphael Kopan et al.   CELL